IT IS A MODERATE CYP2D6 INHIBITOR, THE SYSTEMIC EXPOSURE OF DRUGS METABOLIZED BY CYP2D6 ENZYME SUCH AS METOPROLOL, THIORIDAZINE, FLECAINIDE, PROPAFENONE AND DESIPRAMINE IS INCREASED WHEN CO-ADMINISTERED WITH MIRABEGRON.
WHEN DIGOXIN IS CO-ADMINISTERED ITS LOWEST DOSE SHOULD BE STARTED & THEN GRADUALLY TITRATED DEPENDING ON SERUM CONCENTRATION.